InvestorsHub Logo

Sprycel

01/21/20 12:46 PM

#32017 RE: Releasemas #32015

Here is your answer in case it was missed and maybe this is why EAGLE accepted .0349 for their debt to equity swab in the S1. They are looking into the future:

Just so there is no confusion my investigation into this informs me at the initial launch of the Oral Tab by Symtomax which is a white labelled version of the GCAN elluting tab technology is being supplied by GCAN already loaded with CBD. When Symtomax itself producing its own CBD and medical grade oil later this year out of its facility in Portugal they will be loading the tabs themselves.



There is plenty of Cannabis GCAN can use being currently produced in Europe as has been for years. Across the pond has embraced Cannabis while our politicians fight over it.

JMHO